Variant report
Variant | nsv893639 |
---|---|
Chromosome Location | chr9:104853447-104938113 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000186166 | chromatin interactions |
ENSG00000255121 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545426665 | chr9:104875805-104875806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542225777 | chr9:104875821-104875822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112734801 | chr9:104875841-104875842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567843824 | chr9:104875845-104875846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536971043 | chr9:104875850-104875851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372547496 | chr9:104875916-104875917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189263946 | chr9:104875956-104875957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545237549 | chr9:104876025-104876026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182186045 | chr9:104876026-104876027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560303390 | chr9:104876104-104876105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148580507 | chr9:104876126-104876127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369543292 | chr9:104876141-104876142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34447661 | chr9:104876177-104876178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs386415670 | chr9:104876178-104876179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35552628 | chr9:104876179-104876180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554722556 | chr9:104876180-104876181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575967904 | chr9:104876181-104876182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565608295 | chr9:104876190-104876191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12380477 | chr9:104876647-104876648 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs554266038 | chr9:104876670-104876671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12380493 | chr9:104876691-104876692 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs112872396 | chr9:104876723-104876724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373371253 | chr9:104876761-104876762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141932808 | chr9:104876793-104876794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145769761 | chr9:104876794-104876795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577107587 | chr9:104876870-104876871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373590130 | chr9:104876884-104876885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12380515 | chr9:104876930-104876931 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs534463068 | chr9:104876948-104876949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs117985146 | chr9:104876965-104876966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561374947 | chr9:104876977-104876978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371479871 | chr9:104876996-104876997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs147786920 | chr9:104877007-104877008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550398548 | chr9:104877026-104877027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570143424 | chr9:104877032-104877033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373352326 | chr9:104877055-104877056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12377882 | chr9:104877111-104877112 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs320166 | chr9:104877144-104877145 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs191596687 | chr9:104877179-104877180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12377893 | chr9:104877180-104877181 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs113403798 | chr9:104877186-104877187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7034610 | chr9:104877235-104877236 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs73659244 | chr9:104877268-104877269 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs79585279 | chr9:104877296-104877297 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs576938229 | chr9:104877299-104877300 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12379341 | chr9:104877313-104877314 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs141269382 | chr9:104877332-104877333 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554090555 | chr9:104877387-104877388 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543342288 | chr9:104877408-104877409 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76234070 | chr9:104877413-104877414 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Schizophrenia | 23813976 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:104875800-104876200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr9:104876600-104877200 | Enhancers | Adipose Nuclei | Adipose |
3 | chr9:104877200-104877600 | Flanking Active TSS | Adipose Nuclei | Adipose |
4 | chr9:104878600-104879600 | Enhancers | Fetal Heart | heart |
5 | chr9:104886400-104886800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr9:104886600-104887400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr9:104893200-104893800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr9:104897000-104897600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr9:104897600-104898400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr9:104897800-104899000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr9:104898000-104898400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr9:104904600-104905000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
13 | chr9:104915600-104916000 | Active TSS | iPS-15b Cell Line | embryonic stem cell |